Highlights Tasly Pharmaceutical Group Co., Ltd

Equities

600535

CNE000001C81

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 08/05/2024 am IST			5-day change	1st Jan Change
15.84 ^CNY	-0.44%		+2.46%	-6.93%

25/04	Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat	16/04	MT
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	15/04	CI
Tasly Pharmaceutical Gets Nod to Trial Stem Cell Therapy	19/01	MT
ShuYu Civilian Pharmacy Corp., Ltd. Scraps Plan to Buy Stake in Tasly Pharmaceutical's Two Units	29/12	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Tasly Pharmaceutical Gets Go Ahead to Launch Clinical Trial of Diabetic Kidney Drug	19/22/19	MT
Mauna Kea Technologies and Tasly Pharmaceutical Announces the Incorporation of Joint Venture in China	07/22/07	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Tasly Pharmaceutical Wins Nod For Clinical Trial of Psoriasis Drug	30/22/30	MT
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	19/22/19	CI
Tasly Pharmaceutical Group Scraps Plan to Spin Off BioPharm Unit for Listing	19/22/19	CI
Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements	11/22/11	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.	05/22/05	CI
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.	12/21/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Tasly Pharmaceutical Group Co., Ltd

Equities

600535

CNE000001C81

Highlights

Filters